SH2B3 (LNK) encodes a lymphocyte adaptor protein that functions as a critical negative regulator of cytokine signaling through inhibition of JAK/STAT pathways 1. The protein is predominantly expressed in hematopoietic and endothelial cells and negatively regulates cell proliferation and cytokine receptor signaling 2. SH2B3 controls hematopoietic stem cell homeostasis by modulating cytokine-mediated JAK/STAT activation in CD34+ hematopoietic stem and progenitor cells 1. The protein plays essential roles in suppressing arterial thrombosis by regulating eosinophil and neutrophil activation, preventing neutrophil extracellular trap (NET) formation and eosinophil extracellular trap (EET) formation 34. Loss-of-function variants, particularly the common R262W polymorphism (T allele), reduce SH2B3 function and are associated with increased cardiovascular disease risk, eosinophilia, neutrophilia, and thrombocytosis 53. The variant promotes oxidized phospholipid-dependent NETosis and arterial thrombosis 3. Clinically, SH2B3 variants are linked to coronary heart disease, atrial fibrillation, hypertension, and hematologic malignancies including acute lymphoblastic leukemia where sequence mutations contribute to kinase-activating lesions 67.